Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 15(4): e0231223, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32298286

RESUMO

We observed prominent effects of doxorubicin (Dox), an anthracycline widely used in anti-cancer therapy, on the aggregation and intracellular distribution of both partners of the H2A-H2B dimer, with marked differences between the two histones. Histone aggregation, assessed by Laser Scanning Cytometry via the retention of the aggregates in isolated nuclei, was observed in the case of H2A. The dominant effect of the anthracycline on H2B was its massive accumulation in the cytoplasm of the Jurkat leukemia cells concomitant with its disappearance from the nuclei, detected by confocal microscopy and mass spectrometry. A similar effect of the anthracycline was observed in primary human lymphoid cells, and also in monocyte-derived dendritic cells that harbor an unusually high amount of H2B in their cytoplasm even in the absence of Dox treatment. The nucleo-cytoplasmic translocation of H2B was not affected by inhibitors of major biochemical pathways or the nuclear export inhibitor leptomycin B, but it was completely diminished by PYR-41, an inhibitor with pleiotropic effects on protein degradation pathways. Dox and PYR-41 acted synergistically according to isobologram analyses of cytotoxicity. These large-scale effects were detected already at Dox concentrations that may be reached in the typical clinical settings, therefore they can contribute both to the anti-cancer mechanism and to the side-effects of this anthracycline.


Assuntos
Citoplasma/metabolismo , Doxorrubicina/farmacologia , Histonas/metabolismo , Transporte Ativo do Núcleo Celular , Antraciclinas/farmacologia , Antineoplásicos/farmacologia , Núcleo Celular/metabolismo , Proliferação de Células , Ácidos Graxos Insaturados/metabolismo , Humanos , Células Jurkat , Citometria de Varredura a Laser , Espectrometria de Massas , Microscopia Confocal , Monócitos/citologia
2.
Sci Rep ; 10(1): 3876, 2020 Feb 26.
Artigo em Inglês | MEDLINE | ID: mdl-32099044

RESUMO

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

3.
Sci Rep ; 10(1): 1107, 2020 01 24.
Artigo em Inglês | MEDLINE | ID: mdl-31980698

RESUMO

Unexpectedly, the widely used anticancer agents Cisplatin (Cis-Pt) and Daunorubicin (Dauno) exhibited cell type- and concentration-dependent synergy or antagonism in vitro. We attempted to interpret these effects in terms of the changes elicited by the drugs in the chromatin, the target held primarily responsible for the cytotoxicity of both agents. We measured the effect of Cis-Pt on the levels of Dauno in different cell compartments, the effect of Cis-Pt on Dauno-induced nucleosome eviction, and assessed the influence of Dauno on DNA platination in flow- and laser scanning cytometry as well as in laser ablation-inductively coupled plasma-mass spectrometry assays. We show that the two drugs antagonize each other through a decrease of interstrand crosslinks upon co-treatment with Dauno, and also via the diminished Dauno uptake in the presence of Cis-Pt, and both effects are observed already at low Dauno concentrations. At high Dauno concentrations synergy becomes dominant because histone eviction by Dauno intercalation into the DNA is enhanced in the presence of co-treatment with Cis-Pt. These interactions may have an impact on the efficacy of combination treatment protocols, considering the long retention time of DNA adducts formed by both agents.


Assuntos
Antineoplásicos/farmacologia , Cromatina/efeitos dos fármacos , Cromatina/genética , Cisplatino/farmacologia , Adutos de DNA/efeitos dos fármacos , DNA de Neoplasias/metabolismo , Daunorrubicina/farmacologia , Antineoplásicos/metabolismo , Linhagem Celular Tumoral , Cisplatino/metabolismo , Daunorrubicina/metabolismo , Relação Dose-Resposta a Droga , Interações Medicamentosas , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...